ReviewHematology. American Society of Hematology. Education Program2018

Optimizing the role of brentuximab vedotin in classical Hodgkin lymphoma therapy.

Alison J MoskowitzPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.